| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K09344309 |
| PharmacoGx | BRD-K09344309 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATP6V1D | CTRPv2 | pan-cancer | AAC | -0.17 | 0.07 |
| mRNA | LIN28B | CTRPv2 | pan-cancer | AAC | 0.15 | 0.07 |
| mRNA | RBM34 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.07 |
| mRNA | KLF9 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.07 |
| mRNA | SDC4 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.07 |
| mRNA | LYST | CTRPv2 | pan-cancer | AAC | 0.15 | 0.07 |
| mRNA | FBXL4 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | CTC-260F20.3 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.07 |
| mRNA | NT5DC4 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | GNB1L | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
